- Corporate Officers - A
- Atlas Venture Associates Opportunity I, Llc
Insider Trading History of Atlas Venture Associates Opportunity I, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Atlas Venture Associates Opportunity I, Llc since 2021.
This trader's CIK number is 1780066.
At the time of last reporting, Atlas Venture Associates Opportunity I, Llc was the Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
Note that in the past
Atlas Venture Associates Opportunity I, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Disc Medicine, Inc. (IRON) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | IRON | 0 | $0 | 50,000 | $3,200,000 | 0 | $0 |
| 2023 | IRON | 0 | $0 | 549,163 | $30,710,795 | 0 | $0 |
Yearly summary of insider trading at Generation Bio Co. (GBIO) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | GBIO | 0 | $0 | 432,172 | $11,038,651 | 0 | $0 |
Yearly summary of insider trading at Ikena Oncology, Inc. (IKNA) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IKNA | 125,000 | $2,000,000 | 26,278 | $385,571 | 0 | $0 |
Yearly summary of insider trading at Day One Biopharmaceuticals, Inc. (DAWN) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | DAWN | 766,667 | $11,500,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Xilio Therapeutics, Inc. (XLO) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | XLO | 0 | $0 | 5,235 | $4,240 | 0 | $0 |
Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | KYMR | 0 | $0 | 353,357 | $15,006,227 | 0 | $0 |
| 2022 | KYMR | 0 | $0 | 508,718 | $15,355,304 | 0 | $0 |
Yearly summary of insider trading at Third Harmonic Bio, Inc. (THRD) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | THRD | 1,500,000 | $25,500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vigil Neuroscience, Inc. (VIGL) by Atlas Venture Associates Opportunity I, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | VIGL | 535,000 | $7,490,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 8 companies by Atlas Venture Associates Opportunity I, Llc:
1. Disc Medicine, Inc. (IRON)
2. Generation Bio Co. (GBIO)
3. Ikena Oncology, Inc. (IKNA)
4. Day One Biopharmaceuticals, Inc. (DAWN)
5. Xilio Therapeutics, Inc. (XLO)
6. Kymera Therapeutics, Inc. (KYMR)
7. Third Harmonic Bio, Inc. (THRD)
8. Vigil Neuroscience, Inc. (VIGL)
Table 1. Insider trading of Disc Medicine, Inc. (IRON) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-01-10 | IRON | Sale | 50,000 | 64.00 | 3,200,000 |
| 2023-12-13 | IRON | Sale | 8,871 | 60.24 | 534,433 |
| 2023-12-12 | IRON | Sale | 129,918 | 62.98 | 8,181,715 |
| 2023-12-14 | IRON | Sale | 51,374 | 59.01 | 3,031,322 |
| 2023-08-14 | IRON | Sale | 175,000 | 53.27 | 9,321,725 |
| 2023-08-15 | IRON | Sale | 184,000 | 52.40 | 9,641,600 |
Table 2. Insider trading of Generation Bio Co. (GBIO) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-27 | GBIO | Sale | 51,389 | 25.70 | 1,320,697 |
| 2021-09-29 | GBIO | Sale | 16,586 | 24.59 | 407,849 |
| 2021-09-28 | GBIO | Sale | 13,113 | 25.24 | 330,972 |
| 2021-09-22 | GBIO | Sale | 30,617 | 25.89 | 792,704 |
| 2021-09-23 | GBIO | Sale | 75,465 | 26.27 | 1,982,616 |
| 2021-09-24 | GBIO | Sale | 28,916 | 25.84 | 747,160 |
| 2021-06-24 | GBIO | Sale | 31,008 | 26.08 | 808,688 |
| 2021-06-21 | GBIO | Sale | 63,892 | 24.97 | 1,595,383 |
| 2021-06-22 | GBIO | Sale | 58,577 | 24.98 | 1,463,253 |
| 2021-06-23 | GBIO | Sale | 62,609 | 25.39 | 1,589,329 |
Table 3. Insider trading of Ikena Oncology, Inc. (IKNA) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-14 | IKNA | Sale | 5,959 | 14.00 | 83,426 |
| 2021-12-13 | IKNA | Sale | 8,330 | 14.64 | 121,951 |
| 2021-12-10 | IKNA | Sale | 11,989 | 15.03 | 180,194 |
| 2021-03-30 | IKNA | Buy | 125,000 | 16.00 | 2,000,000 |
Table 4. Insider trading of Day One Biopharmaceuticals, Inc. (DAWN) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-17 | DAWN | Buy | 766,667 | 15.00 | 11,500,005 |
Table 5. Insider trading of Xilio Therapeutics, Inc. (XLO) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-02-08 | XLO | Sale | 1,000 | .64 | 640 |
| 2024-01-11 | XLO | Sale | 2,135 | .87 | 1,857 |
| 2024-01-12 | XLO | Sale | 2,100 | .83 | 1,743 |
Table 6. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-11 | KYMR | Sale | 51,184 | 43.09 | 2,205,774 |
| 2024-03-12 | KYMR | Sale | 162,918 | 42.23 | 6,880,027 |
| 2024-03-13 | KYMR | Sale | 139,255 | 42.52 | 5,920,426 |
| 2022-11-03 | KYMR | Sale | 96,397 | 30.00 | 2,891,910 |
| 2022-11-02 | KYMR | Sale | 123,619 | 30.02 | 3,711,042 |
| 2022-11-01 | KYMR | Sale | 77,030 | 30.82 | 2,374,449 |
| 2022-10-28 | KYMR | Sale | 91,050 | 30.00 | 2,731,500 |
| 2022-10-31 | KYMR | Sale | 120,622 | 30.23 | 3,646,403 |
Table 7. Insider trading of Third Harmonic Bio, Inc. (THRD) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
| 2022-09-19 | THRD | Buy | 300,000 | 17.00 | 5,100,000 |
Table 8. Insider trading of Vigil Neuroscience, Inc. (VIGL) by Atlas Venture Associates Opportunity I, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-11 | VIGL | Buy | 535,000 | 14.00 | 7,490,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Atlas Venture Associates Opportunity I, Llc
(Officer of Kymera Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.